1. Medtronic: The company reported $7.38 billion in first quarter 2019 revenue, a 0.1 percent decrease year-over-year. However, Medtronic saw a 6.8 percent increase in organic revenue growth.
2. DePuy Synthes: The company generated $845 million in second quarter 2018 sales, a 7.7 percent decrease year-over-year. The company’s trauma segment reported $675 million in sales, a 5 percent increase.
3. NuVasive: NuVasive experienced an 8.5 percent increase in year-over-year revenues, topping $281.6 million for the second quarter of 2018.
4. Stryker: Stryker reported $3.3 billion in net sales, a 10.3 percent increase year-over-year.
5. Globus Medical: The company’s sales spiked 13.8 percent year-over-year, reaching $173.4 million for the second quarter of 2018.
6. Zimmer Biomet: The company reported $2 billion in sales during the second quarter of 2018, a 3 percent increase year-over-year.
7. K2M: The company’s second quarter of 2018 revenue was $73.6 million, a 12 percent increase year-over-year.
8. Orthofix: Orthofix’s sales for the second quarter of 2018 jumped to $111.5 million, a 2.4 percent increase year-over-year.
9. Alphatec: Alphatec reported a 6 percent increase in net revenue during the second quarter of 2018, hitting $22 million.
10. RTI Surgical: The company reported $70.7 million in revenue for the second quarter of 2018, compared to $72.1 million in the same quarter the prior year.
More articles on devices and implants:
Kathie Lenzen joins Xtant Medical as CFO: 4 things to know
Medtronic, IRS dispute over $1.4B sent back to U.S. Tax Court: 4 key notes
These device companies pay physicians the most
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
